GOVERNMENT COUNSEL, LLC for PRIME THERAPEUTICS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues relating to prescription benefit manager transparency; S.1339-Pharmacy Benefit Manager Reform Act; H.R. 5378-The Lower Costs, More Transparency Act; S. 1542/H.R. 6283 The Delinking Revenue from Unfair Gouging (DRUG) Act-provisions dictating PBM contracting terms.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HENRY W MENN | Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner. |
Medicare/Medicaid MMM
H.R. 7623-Telehealth Modernization Act of 2024 relating to sec. 202 arrangements with PBMs; S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430-Better Mental Health Care, Lower-Cost Drugs, and Extenders Act relating to Title 2 reducing prescription drug costs; H.R. 5526-Seniors Access to Critical Medications Act of 2023 provisions clarifying Medicare so that delivery of medicines through various methods or by allowing a family member or caregiver to pick up medication on behalf of a patient does not violate the Stark Law and does fall within the scope of Stark's IOAS exception.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HENRY W MENN | Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.